Transitional care for stroke patients
An Experimental Study of the Application of Transitional Care Model on Patients With Stroke
NA · Kaohsiung Medical University · NCT06280599
This study tests a new support program for stroke patients to see if it helps them recover better and feel more supported during and after their hospital stay.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Kaohsiung Medical University (other) |
| Locations | 1 site (Kupang) |
| Trial ID | NCT06280599 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a transitional care model designed to support stroke patients during their recovery process. It aims to address the unmet needs of patients and caregivers by providing timely strategies for communication, recovery planning, and emotional support during hospitalization and after discharge. The model has been developed to improve physical function, reduce emergency room visits, and enhance overall quality of life for stroke survivors. Participants will be monitored during their hospital stay and for eight weeks post-discharge to assess the impact of the intervention.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been admitted to the neurology department for stroke treatment and can communicate in Indonesian.
Not a fit: Patients with cognitive impairments, major speech issues, serious psychiatric disorders, or those being discharged to nursing homes may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve recovery outcomes and quality of life for stroke patients.
How similar studies have performed: While transitional care models have been implemented widely, the effectiveness of this specific approach remains inconclusive, indicating a need for further investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being at least 18 years old, being admitted in neurology department for at least 24 to 48 hours, * Not having cognitive impairment as measured by the Montreal cognitive assessment (score ≥ 23), * Being able to communicate in Indonesia, having the ability to provide informed consent, * Being willing to participate in this study during hospitalization and 8 weeks after hospital discharge Exclusion Criteria: * Have potentially biased information, such as being unable to provide informed consent due to cognitive impairment, * Having major speech and language problems or aphasia that prevent them from participating in the study, * Having serious psychiatric disorders or other with terminal disease requiring active treatment, and * Being discharged to a nursing home or welfare institution.
Where this trial is running
Kupang
- RSUD Prof. Dr. W Z Johannes Kupang — Kupang, Indonesia (RECRUITING)
Study contacts
- Study coordinator: Ita Saragih, PhD student
- Email: itadaryanti05@gmail.com
- Phone: +886 986 226143
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke